Skip to Content

User Reviews for Pralatrexate

Also known as: Folotyn

Pralatrexate has an average rating of 1.0 out of 10 from a total of 1 ratings on 0% of those users who reviewed Pralatrexate reported a positive effect, while 100% reported a negative effect.

Condition Avg. Rating Reviews Compare
Peripheral T-cell Lymphoma   1.0
1 reviews 3 medications
Summary of Pralatrexate reviews 1.0 1 reviews

Reviews may be moderated or edited before publication to correct grammar and spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest in the medication will not be published. As reviews and ratings are subjective and self-reported, this information should not be used as the basis for any statistical analysis or scientific studies.

ptim · Taken for 1 to 6 months February 10, 2016

Folotyn (pralatrexate) for Peripheral T-cell Lymphoma: “My wife had two weekly treatments and developed a high fever, low blood counts, weakness, and confusion and was unable to continue. 15 days in the hospital to come back to previous condition. As there were other issues involved Folotyn was not determined to be the sole cause of her problems. We waited 9 weeks and tried another treatment of Folotyn, one week later we were back in the hospital for 12 days. This has not been a viable treatment for her as it has also had no effect on her PTCL NOS. We will most likely be trying Istodax next.”

1 / 10

This information is NOT intended to endorse any particular medication. While these reviews might be helpful, they are not a substitute for the expertise, knowledge and judgement of healthcare practitioners.